Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $1.71
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Mar 12, 26 |
Daily · Wilder smoothing
| Roth Capital |
| maintain |
| Neutral |
| Neutral |
| Mar 14, 25 | Roth MKM | maintain | Neutral | Neutral |
| Nov 15, 24 | Benchmark | maintain | Buy | Buy |
| May 16, 24 | Benchmark | maintain | Buy | Buy |
| Mar 25, 24 | Benchmark | maintain | Buy | Buy |
| Mar 22, 24 | Maxim Group | upgrade | Hold | Buy |
| Nov 16, 23 | Benchmark | maintain | Buy | Buy |
| Aug 4, 23 | Roth MKM | downgrade | Buy | Neutral |
| May 5, 23 | EF Hutton | maintain | Buy | Buy |
Classic floor pivots from 2026-10-26
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 32.13 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 7.92 | Oscillator | Buy |
| Williams %R (14) | -97.30 | Oscillator | Buy |
| MACD (12, 26, 9) | -0.11 (Hist -0.01) | Oscillator | Strong Sell |
| Average Directional Index (14) | 36.62 (+DI 7.7 / -DI 30.7) | Trend | Strong Sell |
| EMA 20 | 1.90 | MA | Strong Sell |
| SMA 20 | 1.92 | MA | Strong Sell |
| EMA 50 | 2.06 | MA | Strong Sell |
| SMA 50 | 2.13 | MA | Strong Sell |
| SMA 200 | 2.51 | MA | Strong Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Boyer Bonnie Alice | officer | 0 | — | |
| Aug 8, 26 | Busquet Anne | director | M-Exempt | 7,500 | — |
| Aug 8, 26 | Busquet Anne | director | M-Exempt | 7,500 | — |
| Aug 8, 26 | Korn Bill | director | M-Exempt | 7,500 | — |
| Aug 8, 26 | Korn Bill | director | M-Exempt | 7,500 | — |
| Aug 8, 26 | Munter Cameron | director | M-Exempt | 7,500 | — |
| Aug 8, 26 | Munter Cameron | director | M-Exempt | 7,500 | — |
| Aug 8, 26 | Sharnak Lawrence Steven | director | M-Exempt | 7,500 | — |
FY2025 · 10-K disclosure
Stock news · updated daily
Evolent Health (NYSE: EVH - Get Free Report) and CareCloud (NASDAQ: CCLD - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Valuation and Earnings This table compares Evolent Health
SOMERSET, N.J., Oct. 15, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the third quarter ended September 30, 2026 before the market opens on Thursday, November 5, 2026. The Company will host a conference call at 8:30 a.m. Eastern Time that morning to discuss the results.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | 0.02 | 0.04 | Beat 71.5% | $31.88M |
| May 7, 2026 | 0.06 | -0.01 | Miss -116.7% | $31.27M |
| Mar 12, 2026 | 0.11 | 0.04 | Miss -63.6% | $34.42M |
| Nov 6, 2025 | 0.08 | 0.04 | Miss -50.0% | $31.07M |
| Aug 5, 2025 | 0.08 | 0.07 | Miss -12.5% | $27.38M |
| May 6, 2025 | 0.07 | -0.04 | Miss -157.1% | $27.60M |
TTM vs. 5-year historical average (annual ratios)
| Metric | CCLD | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 24.5x | 1.2x · sector 20.7x | Elevated |
| Forward P/E (FY26E) | 6.2x | EPS est. 0.28 | Discount |
| Price / Book | 4.2x | 1.0x | Elevated |
| Price / Sales | 0.6x | 0.5x | In line |
| EV / EBITDA | 4.0x | 2.5x | Elevated |
| Return on equity | 16.6% | — | Healthy |
| Gross margin | 31.7% | 41.6% | Below hist. |
| Debt / Equity | 3.10 | 0.16 | Levered |
| Piotroski / Altman Z | 4/9 | Z 1.50 | Distress |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 3 | Oct 5, 2026 | 2026-10-05 21:29:54 | View |
| 8-K | Sep 29, 2026 | 2026-09-29 08:40:42 | View |
| 4 | Aug 10, 2026 | 2026-08-10 21:30:06 | View |
| 4 | Aug 10, 2026 | 2026-08-10 21:30:04 | View |
| 4 | Aug 10, 2026 | 2026-08-10 21:30:03 | View |
| 4 | Aug 10, 2026 | 2026-08-10 21:30:01 | View |
| 10-Q | Aug 6, 2026 | 2026-08-06 16:30:55 | View |
| 8-K | Aug 6, 2026 | 2026-08-06 07:10:26 | View |
| 4 | Jul 31, 2026 | 2026-07-31 21:30:05 | View |
| 4 | Jul 31, 2026 | 2026-07-31 21:30:03 | View |
Proxy statement (DEF 14A) disclosures